Abstract
An immunologic component to schizophrenia has been increasingly recognized, where infections and chronic inflammatory diseases as atopic disorders and autoimmune diseases could be involved in the pathogenesis of schizophrenia. Psychotic symptoms can be directly triggered by infections reaching the CNS, or be secondary to systemic inflammation indirectly affecting the brain through immune components, such as brain-reactive antibodies and cytokines. Large-scale epidemiological studies have consistently displayed that infections, autoimmune diseases, and atopic disorders are associated with increased risk of schizophrenia and that schizophrenia is associated with increased levels of immune markers at diagnosis. However, since there is also an increased risk of immune-related diseases after the diagnosis with schizophrenia and in family members of individuals with schizophrenia, parts of the association could also be due to heritable factors. Shared genetic factor might account for some of this increased prevalence of immune-related diseases among individuals with schizophrenia, and indeed the most pronounced genetic association with schizophrenia lies within the HLA region, which is one of the most important regions for the immune system. However, genetic studies have shown that the common genetic variants associated with schizophrenia do not seem to increase the susceptibility for acquiring infections. Nonetheless, shared genes with the susceptibility for acquiring infections not captured by the polygenic risk score for schizophrenia could still influence the association.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrahao AL, Focaccia R, Gattaz WF (2005) Childhood meningitis increases the risk for adult schizophrenia. World J Biol Psychiatry 6:44–48
Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345:99–103
Arias I, Sorlozano A, Villegas E et al (2012) Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res 136:128–136
Bartova L, Rajcani J, Pogady J (1987) Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients. Acta Virol 31:443–446
Bechter K (2012) Updating the mild encephalitis hypothesis of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2012.06.019
Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG (2010) Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res 44:321–330
Benros M, Nielsen P (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168:1303–1310
Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168:1303–1310
Benros ME, Mortensen PB, Eaton WW (2012) Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci 1262:56–66
Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB (2014) A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry 171:218–226
Benros ME, Trabjerg BB, Meier S et al (2016) Influence of polygenic risk scores on the association between infections and schizophrenia. Biol Psychiatry 80:609–616
Birnbaum R, Jaffe AE, Chen Q et al (2017) Investigating the neuroimmunogenic architecture of schizophrenia. Nat Publ Group 23:1251–1260
Blomstrom A, Karlsson H, Svensson A et al (2014) Hospital admission with infection during childhood and risk for psychotic illness – a population-based cohort study. Schizophr Bull 40:1518–1525
Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280
Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES (2005) Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162:767–773
Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH (2001) Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58:1032–1037
Butterworth RF (2011) Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53:1372–1376
Cascella NG, Kryszak D, Bhatti B et al (2011) Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull 37:94–100
Chen CH, Chiu YL, Wei FC et al (1999) High seroprevalence of Borna virus infection in schizophrenic patients, family members and mental health workers in Taiwan. Mol Psychiatry 4:33–38
Chen S-J, Chao Y-L, Chen C-Y et al (2012) Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 200:374–380
Crump C, Winkleby MA, Sundquist K, Sundquist J (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 170:324–333
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712
Dalman C, Allebeck P, Gunnell D et al (2008) Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry 165:59–65
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56
Darby MM, Yolken RH, Sabunciyan S (2016) Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders. Nat Publ Group 6:e890
Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT (2009) Losing your nerves? Maybe it’s the antibodies. Nat Rev Immunol 9:449–456
Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH (2003) Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 60:466–472
Dickerson F, Stallings C, Origoni A et al (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68:100–104
Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, Drexhage HA (2010) Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 13:1369–1381
Eaton WW, Hayward C, Ram R (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr Res 6:181–192
Eaton WW, Byrne M, Ewald H et al (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163:521–528
Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB (2010) Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 12:638–646
Fellerhoff B, Wank R (2011) Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia. Schizophr Res 129:191–195
Fellerhoff B, Laumbacher B, Mueller N, Gu S, Wank R (2007) Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10. Mol Psychiatry 12:264–272
Fessel WJ (1962) Autoimmunity and mental illness. A preliminary report. Arch Gen Psychiatry 6:320–323
Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 197:597–607
Gandal MJ, Haney JR, Parikshak NN et al (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693–697
Gardiner EJ, Cairns MJ, Liu B et al (2013) Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. J Psychiatr Res 47:425–437
Gilvarry CM, Sham PC, Jones PB et al (1996) Family history of autoimmune diseases in psychosis. Schizophr Res 19:33–40
Goldsmith C-AW, Rogers DP (2008) The case for autoimmunity in the etiology of schizophrenia. Pharmacotherapy 28:730–741
Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709
Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393–407
Graff H, Handford A (1961) Celiac syndrome in the case histories of five schizophrenics. Psychiatry Q 35:306–313
Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509–517
Hart DJ, Heath RG, Sautter FJ Jr et al (1999) Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biol Psychiatry 45:704–714
Hartwig FP, Borges MC, Horta BL, Bowden J, Smith GD (2017) Inflammatory biomarkers and risk of schizophrenia: a 2-sample mendelian randomization study. JAMA Psychiatry 74(12):1226–1233
Heath RG, Krupp IM (1967a) Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gen Psychiatry 16:1–9
Heath RG, Krupp IM (1967b) Catatonia induced in monkeys by antibrain antibody. Am J Psychiatry 123:1499–1504
Hickie IB, Banati R, Stewart CH, Stewart CH, Lloyd AR (2009) Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders? Med J Aust 190:S17–S21
Hwang Y, Kim J, Shin J, Kim J (2013) Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry 3:e321–e329
Irani S, Lang B (2008) Autoantibody-mediated disorders of the central nervous system. Autoimmunity 41:55–65
Kalaydjian AE, Eaton W, Cascella N, Fasano A (2006) The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 113:82–90
Karim S, Kamal MA, Iqbal Z et al (2016) Global expression studies of schizophrenic brain: a meta-analysis study linking neurological immune system with psychological disorders. CNS Neurol Disord Drug Targets 15:477–488
Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH (2001) Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci U S A 98:4634–4639
Katzav A, Solodeev I, Brodsky O et al (2007) Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 56:938–948
Kayser MS, Dalmau J (2011) Anti-NMDA receptor encephalitis in psychiatry. Curr Psychiatr Rev 7:189–193
Kayser MS, Kohler CG, Dalmau J (2010) Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry 167:1039–1050
Khandaker GM, Zimbron J, Dalman C, Lewis G, Jones PB (2012) Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res 139:161–168
Khandaker GM, Zammit S, Lewis G, Jones PB (2014) A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophr Res 152:139–145
Khandaker GM, Zammit S, Burgess S, Lewis G, Jones PB (2018) Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain Behav Immun 69:264–272
Kim KS (2008) Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 6:625–634
Kimura A, Sakurai T, Koumura A et al (2010) High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases. J Neuroimmunol 219:105–108
Köhler O, Petersen L, Mors O et al (2017) Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr Scand 135:97–105
Koponen H, Rantakallio P, Veijola J, Jones P, Jokelainen J, Isohanni M (2004) Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:9–13
Kowal C, Degiorgio LA, Nakaoka T et al (2004) Cognition and immunity; antibody impairs memory. Immunity 21:179–188
Laan W, Smeets H, de Wit NJ, Kahn RS, Grobbee DE, Burger H (2009) Glucocorticosteroids associated with a decreased risk of psychosis. J Clin Psychopharmacol 29:288–290
Laske C, Zank M, Klein R et al (2008) Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Res 158:83–86
Leweke FM, Gerth CW, Koethe D et al (2004) Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:4–8
Liang W, Chikritzhs T (2012) Early childhood infections and risk of schizophrenia. Psychiatry Res 200:214–217
Margutti P, Delunardo F, Ortona E (2006) Autoantibodies associated with psychiatric disorders. Curr Neurovasc Res 3:149–157
Mednick SA, Machon RA, Huttunen MO, Bonett D (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189–192
Metcalf SA, Jones PB, Nordstrom T et al (2017) Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study. Brain Behav Immun 59:253–259
Meyer U, Schwarz MJ, Müller N (2011a) Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol Ther 132:96–110
Meyer U, Feldon J, Dammann O (2011b) Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69:26R–33R
Mors O, Mortensen PB, Ewald H (1999) A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr Res 40:67–74
Mortensen PB, Norgaard-Pedersen B, Waltoft BL et al (2007) Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 61:688–693
Muller NJ, Schwarz M (2010) The role of immune system in schizophrenia. Curr Immunol Rev 6:213–220
Niebuhr DW, Millikan AM, Yolken R, Li Y, Weber NS (2008) Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnel. Schizophr Bull 34:1182–1188
Nielsen PR, Laursen TM, Mortensen PB (2013) Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood. Schizophr Bull 39:230–237
Nielsen PR, Benros ME, Mortensen PB (2014) Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers. Schizophr Bull 40:1526–1532
Nikkilä HV, Müller K, Ahokas A, Rimón R, Andersson LC (2001) Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 49:99–105
Noll R (2007) Kraepelin’s ‘lost biological psychiatry’? Autointoxication, organotherapy and surgery for dementia praecox. Hist Psychiatry 18:301–320
Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M (2006) Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59:546–554
Patterson PH (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204:313–321
Pedersen A, Zachariae R, Bovbjerg DH (2010) Influence of psychological stress on upper respiratory infection – a meta-analysis of prospective studies. Psychosom Med 72:823–832
Pedersen MG, Stevens H, Pedersen CB, Norgaard-Pedersen B, Mortensen PB (2011) Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry 168:814–821
Pedersen MS, Benros ME, Agerbo E, Børglum AD, Mortensen PB (2012) Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res 138:58–62
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808
Pouget JG, Gonçalves VF, Spain SL et al (2016) Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases. Schizophr Bull 42:1176–1184
Prins BP, Abbasi A, Wong A et al (2016) Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med 13:1–29
Ripke S, Neale BM, Corvin A et al (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427
Rose NR (1998) The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 10:5–13
Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E (2007) Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7:46
Sainz J, Mata I, Barrera J, Varela I, Arranz MJ, Rodriguez MC (2012) Inflammatory and immune response genes have significantly altered expression in schizophrenia. Mol Psychiatry 18:1056–1057
Samaroo D, Dickerson F, Kasarda DD et al (2010) Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 118:248–255
Sanders AR, Drigalenko EI, Duan J et al (2017) Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis. Transl Psychiatry 7:e1093
Sekar A, Bialas AR, de Rivera H et al (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530:177–183
Sellgren C, Frisell T, Lichtenstein P, Landen M, Askling J (2014) The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr Bull 40:1552–1559
Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B (1992) Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol 66:992–998
Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372–377
Sperner-Unterweger B (2005) Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 65:1493–1520
Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM (2014) Genetic liability for schizophrenia predicts risk of immune disorders. Schizophr Res 159:347–352
Sullivan PF, Daly MJ, O’Donovan M (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13:537–551
Suvisaari J, Mautemps N, Haukka J, Hovi T, Lönnqvist J (2003) Childhood central nervous system viral infections and adult schizophrenia. Am J Psychiatry 160:1183–1185
Torrey EF, Yolken RH (2001) The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immun 15:401–410
Torrey E, Yolken R, Winfrey J (1982) Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 216:892–894
Torrey EF, Leweke MF, Schwarz MJ et al (2006) Cytomegalovirus and schizophrenia. CNS Drugs 20:879–885
Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33:729–736
Torrey EF, Bartko JJ, Yolken RH (2012) Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38:642–647
Trevathan R, Tatum JC (1953) Rarity of concurrence of psychosis and rheumatoid arthritis in individual patients. J Nerv Ment Dis 120:83–84
Wang WC, Lu ML, Chen VC et al (2017) Asthma, corticosteroid use and schizophrenia: a nationwide population-based study in Taiwan. PLoS One 12:e0173063
Weiser M, Werbeloff N, Levine A et al (2010) CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res 124:231–235
Wilkinson J, Radkowski M, Eschbacher JM, Laskus T (2010) Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 59:1394–1400
Wium-Andersen MK, Ørsted DD, Nordestgaard BG (2014) Elevated C-reactive protein associated with late-and very-late-onset schizophrenia in the general population: a prospective study. Schizophr Bull 40:1117–1127
Wright P, Sham PC, Gilvarry CM et al (1996) Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophr Res 20:261–267
Xu J, Sun J, Chen J et al (2012) RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia. BMC Genomics 13:S2
Yolken RH, Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 13:470–479
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Benros, M.E., Mortensen, P.B. (2019). Role of Infection, Autoimmunity, Atopic Disorders, and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies. In: Khandaker, G., Meyer, U., Jones, P. (eds) Neuroinflammation and Schizophrenia. Current Topics in Behavioral Neurosciences, vol 44. Springer, Cham. https://doi.org/10.1007/7854_2019_93
Download citation
DOI: https://doi.org/10.1007/7854_2019_93
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-39140-9
Online ISBN: 978-3-030-39141-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)